Skip to main content

Table 2 Transmission drug resistance among ART naïve HIV-1 infections from Guangdong China

From: Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study

Subtypes

Number

Number of TDR

Prevalence (%)

Prevalence (%)

PI

NRTI

NNRTI

CRF07_BC

850

10

1.18

0.12 (1/850)

0.82 (7/850)

0.24 (2/850)

CRF01_AE

842

24

2.85

0.71 (6/842)

0.95 (8/842)

1.31 (11/842)

CRF55_01B

244

5

2.05

0

1.64 (4/244)

0.41 (1/244)

Subtype B

70

3

4.29

1.43 (1/70)

0

2.86 (2/70)

CRF08_BC

66

2

3.03

0

1.52 (1/66)

1.52 (1/66)

CRF59_01B

53

1

1.89

0

(0/53)

1.89 (1/53)

Other

243

7

2.88

0

0.82 (2/243)

2.06 (5/243)

 Subtype C

11

2

18.18

0

0

18.18 (2/11)

 Subtype G

3

0

0

0

0

0

 CRF02_AG

3

0

0

0

0

0

 CRF12_BF

1

0

0

0

0

0

Recombinant strain

225

5

2.22

(0/225)

0.89 (2/225)

1.33 (3/225)

Total

2368

52

2.20

0.34 (8/2368)

0.93 (22/2368)

0.97 (23/2368)

  1. TDR, transmission drug resistance; PI, protease inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor